Avanos Medical, Inc. reported net sales of $167.5 million for the first quarter of 2025, an increase of 0.8% year-over-year. The company's net income was $6.6 million, and adjusted diluted earnings per share were $0.26. Operating income significantly improved to $10.3 million from $4.0 million in the prior year.
Net sales for Q1 2025 increased by 0.8% to $167.5 million.
Operating income rose to $10.3 million in Q1 2025, up from $4.0 million in Q1 2024.
Adjusted diluted earnings per share were $0.26, compared to $0.22 in the prior year.
Cash flow from operations was an inflow of $25.7 million, a significant improvement from an outflow of $8.0 million a year ago.
Avanos Medical is maintaining its 2025 estimated revenue guidance but lowering its estimated adjusted diluted earnings per share range due to the impact of recently announced tariffs.
Analyze how earnings announcements historically affect stock price performance